These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23456868)

  • 1. Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
    Cervellini I; Ghezzi P; Mengozzi M
    Methods Mol Biol; 2013; 982():163-73. PubMed ID: 23456868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
    Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
    J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
    Lev N; Barhum Y; Melamed E; Offen D
    Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of erythropoietin therapy on experimental autoimmune encephalomyelitis.
    Zhang X; Li QY; Xiao BG
    Int J Neurosci; 2012 May; 122(5):255-62. PubMed ID: 22176555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
    Cobo M; Anderson P; Benabdellah K; Toscano MG; Muñoz P; García-Pérez A; Gutierrez I; Delgado M; Martin F
    Cell Transplant; 2013; 22(5):839-54. PubMed ID: 23031550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.
    Sättler MB; Merkler D; Maier K; Stadelmann C; Ehrenreich H; Bähr M; Diem R
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S181-92. PubMed ID: 15459752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
    Zagon IS; Rahn KA; Turel AP; McLaughlin PJ
    Exp Biol Med (Maywood); 2009 Nov; 234(11):1383-92. PubMed ID: 19855075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
    Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
    Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis.
    Mir S; Ali F; Chauhan D; Arora R; Khan HA
    Metab Brain Dis; 2016 Apr; 31(2):299-309. PubMed ID: 26477945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.